Aurora kinase inhibitor tozasertib suppresses mast cell activation in vitro and in vivo.
Li-Na ZhangKunmei JiYue-Tong SunYi-Bo HouJia-Jie ChenPublished in: British journal of pharmacology (2020)
The Aurora kinase inhibitor tozasertib suppressed mast cell activation in vitro and in vivo. Tozasertib may be a potential drug, targeting mast cell activation, to treat allergic diseases or mastocytosis.